Schedule 13G ownership disclosure

CLOVIS ONCOLOGY INC

Security class unavailable · CUSIP: 189464100

Event date: 2019-08-15

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,871,518
Percent of class
5.2500%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001085146-19-002391
Form type
SC 13G
Filer
Clovis Oncology, Inc.
CIK
CIK 1466301
Filed
Aug 20, 2019
Reporting period
Aug 15, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub